NeuroSense Therapeutics Ltd. (NRSN) Return on equity
NeuroSense Therapeutics Ltd. (NRSN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to NRSNSource: SEC XBRL filings · For reference only · Not investment advice
More NRSN financial trends
NRSN RevenueNRSN Net incomeNRSN Net marginNRSN Gross profitNRSN Gross marginNRSN Operating incomeNRSN Operating marginNRSN Operating cash flowNRSN Free cash flowNRSN Capital expendituresNRSN Stock buybacksNRSN Dividends paidNRSN Total assetsNRSN Total liabilitiesNRSN Shareholders’ equityNRSN overview →